Gracell Biotechnologies
A clinical-stage biotech company with mission to solve CAR-T industry hurdles.
Launch date
Employees
Market cap
€900m
Enterprise valuation
€699m (Public information from Feb 2024)
Share price
$10.25 GRCL
Shanghai Shanghai (HQ)
Authorizing premium user...